Google
×
Feb 7, 2019 · Neuralstem is a biopharmaceutical company developing novel treatments for nervous system diseases of high unmet medical need.
CURE Pharmaceutical Investor Video Webcast | Dec. 17 2020. On the Investor Video Webcast, Rob Davidson, CEO of CURE ... Investor Relations. (805) 410-9962 ext. 4.
Missing: cur | Show results with:cur
Investor Relations · Latest News · Latest Events & Presentation · Meet CuriosityStream · Quick Links · IR Contact · Investor Email Alerts · Email Alert Sign Up ...
Missing: cur | Show results with:cur
The Investor Relations website contains information about Cue Health Inc.'s business for stockholders, potential investors, and financial analysts.
Jun 10, 2021 · (“CUR” or the “Company”) (TSXV: CUR) is pleased to announce that it has engaged Mars Investors Relations Inc. (“Mars”), a full services investor ...
The Investor Relations website contains information about NextCure, Inc.'s business for stockholders, potential investors, and financial analysts.
Missing: cur | Show results with:cur
How can I contact Investor Relations? You can contact investor relations through the Contact Us page of this site. CURO Management, LLC. Contact Us. Email ...
Missing: cur | Show results with:cur
Armstrong World Industries Investor Presentation · Safe Harbor Statement · Basis of Presentation Explanation · GAAP and Non-GAAP Financial Results · Armstrong World ...
Find corporate information, shareholder circulars, year-on-year financial results, vision and business objectives regarding Curro Holdings Independent ...
People also ask
Investor Relations. NYSE: MBC16.48. -0.49 ( -2.89 ... Investor Presentation. February 27, 2024. Forward Looking ... cur. ren. t plans and. expectations of our ...